🚀 VC round data is live in beta, check it out!
JFL Life Sciences Valuation Multiples
Discover revenue and EBITDA valuation multiples for JFL Life Sciences and similar public comparables like Geovax Labs, Cannabis Poland, Double Bond, Genetic Technologies and more.
JFL Life Sciences Overview
About JFL Life Sciences
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
Founded
2010
HQ
Employees
39
Website
Sectors
Financials (FY)
EV
$5M
JFL Life Sciences Financials
JFL Life Sciences reported last fiscal year revenue of $9M and EBITDA of $877K.
In the same fiscal year, JFL Life Sciences generated $2M in gross profit, $877K in EBITDA, and $449K in net income.
JFL Life Sciences P&L
In the most recent fiscal year, JFL Life Sciences reported revenue of $9M and EBITDA of $877K.
JFL Life Sciences expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $9M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA | — | XXX | $877K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Profit | — | XXX | $449K | XXX | XXX | XXX |
| Net Margin | — | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
JFL Life Sciences Stock Performance
JFL Life Sciences has current market cap of $4M, and enterprise value of $5M.
Market Cap Evolution
JFL Life Sciences' stock price is $0.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $4M | 0.5% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJFL Life Sciences Valuation Multiples
JFL Life Sciences trades at 0.5x EV/Revenue multiple, and 5.4x EV/EBITDA.
JFL Life Sciences Financial Valuation Multiples
As of April 19, 2026, JFL Life Sciences has market cap of $4M and EV of $5M.
Equity research analysts estimate JFL Life Sciences' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
JFL Life Sciences has a P/E ratio of 8.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4M | XXX | $4M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 5.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 6.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.7x | XXX | XXX | XXX |
| P/E | — | XXX | 8.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (11.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified JFL Life Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
JFL Life Sciences Margins & Growth Rates
JFL Life Sciences' revenue in the last fiscal year grew by 12%.
JFL Life Sciences' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
JFL Life Sciences Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 11% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 11% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
JFL Life Sciences Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| JFL Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Geovax Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Cannabis Poland | XXX | XXX | XXX | XXX | XXX | XXX |
| Double Bond | XXX | XXX | XXX | XXX | XXX | XXX |
| Genetic Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Strategic Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JFL Life Sciences M&A Activity
JFL Life Sciences acquired XXX companies to date.
Last acquisition by JFL Life Sciences was on XXXXXXXX, XXXXX. JFL Life Sciences acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by JFL Life Sciences
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJFL Life Sciences Investment Activity
JFL Life Sciences invested in XXX companies to date.
JFL Life Sciences made its latest investment on XXXXXXXX, XXXXX. JFL Life Sciences invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by JFL Life Sciences
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout JFL Life Sciences
| When was JFL Life Sciences founded? | JFL Life Sciences was founded in 2010. |
| Where is JFL Life Sciences headquartered? | JFL Life Sciences is headquartered in India. |
| How many employees does JFL Life Sciences have? | As of today, JFL Life Sciences has over 39 employees. |
| Is JFL Life Sciences publicly listed? | Yes, JFL Life Sciences is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of JFL Life Sciences? | JFL Life Sciences trades under JFLLIFE ticker. |
| When did JFL Life Sciences go public? | JFL Life Sciences went public in 2022. |
| Who are competitors of JFL Life Sciences? | JFL Life Sciences main competitors are Geovax Labs, Cannabis Poland, Double Bond, Genetic Technologies. |
| What is the current market cap of JFL Life Sciences? | JFL Life Sciences' current market cap is $4M. |
| What is the current revenue of JFL Life Sciences? | JFL Life Sciences' last fiscal year revenue is $9M. |
| What is the current EV/Revenue multiple of JFL Life Sciences? | Current revenue multiple of JFL Life Sciences is 0.5x. |
| Is JFL Life Sciences profitable? | No, JFL Life Sciences is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.